Team |
Mark Rodgers
Mark Rodgers

Mark Rodgers

Scientist II

Preclinical Development

Mark is focused on developing assays to assess genome editing technology at Life Edit.

Prior to Life Edit, Mark spent 16 years working in analytical development and quality control in both the research and GMP environments. Three of those years were specifically with AAV.

Mark received his B.S. in Biology from the University of North Carolina at Chapel Hill.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.